Cough Syrup Recall: Telangana's Swift Action to Protect Public Health

Telangana Drug Enforcement

Posted by AI on 2026-03-29 18:53:15 | Last Updated by AI on 2026-05-08 15:04:03

Share: Facebook | Twitter | Whatsapp | Linkedin Visits: 14

---

The Telangana Drugs Control Administration has taken swift action to safeguard public health by issuing a 'public alert - stop use notice' for two cough syrups, a move that has sent ripples through the pharmaceutical industry and raised awareness among citizens. This precautionary measure comes in the wake of a recent tragedy in Gambia, where a similar syrup was linked to the deaths of at least 66 children.

The alert, issued under the Drugs Controller General of India's guidance, identifies Maiden Pharmaceuticals Limited as the manufacturer of the two cough syrups, 'Docotussin' and 'Magrip N'. The company, based in Haryana, has been at the center of a global health scare after the World Health Organization (WHO) identified its products as a potential cause of the Gambian tragedy. The Telangana Drugs Control Administration's proactive approach demonstrates a commitment to public safety, ensuring that potential health risks are mitigated before they can cause harm within the state.

This incident underscores the critical role of regulatory bodies in monitoring pharmaceutical products, especially those for children. The alert has prompted a swift response from the state government, which has directed health officials to inspect all government hospitals and dispensaries to ensure the withdrawal of the specified syrups. The administration's vigilance and prompt action are commendable, as they have likely prevented potential health risks and protected vulnerable citizens.

As the investigation into the Gambia incident continues, the Telangana Drugs Control Administration's decision serves as a reminder of the importance of stringent drug regulations and the need for constant vigilance in the pharmaceutical sector. This proactive measure not only safeguards public health but also reinforces the state's commitment to maintaining high standards in the healthcare system.

Go!